Back to top
more

Avantor (AVTR)

(Real Time Quote from BATS)

$22.92 USD

22.92
10,207,133

+0.55 (2.46%)

Updated Jul 25, 2024 12:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 250)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Reasons Why You Should Hold Avantor (AVTR) Stock for Now

by Zacks Equity Research

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

Avantor (AVTR) Launches Solutions for Gene Therapy Harvest

by Zacks Equity Research

Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus improving viral particle harvest and quality

Reasons Why You Should Retain Avantor (AVTR) Stock for Now

by Zacks Equity Research

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

Avantor (AVTR) Q1 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.

The Zacks Analyst Blog Highlights Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare

by Zacks Equity Research

Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare are part of the Zacks top Analyst Blog.

Is a Surprise Coming for Avantor (AVTR) This Earnings Season?

by Zacks Equity Research

Avantor (AVTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ELV or AVTR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ELV vs. AVTR: Which Stock Is the Better Value Option?

Kaibalya Pravo Dey headshot

Stay Ahead With 4 Healthcare Stocks Poised for Q1 Earnings Beat

by Kaibalya Pravo Dey

Growing patient volumes, advancements in technology, admissions, premium rate hikes and other factors are likely to have benefited healthcare players during Q1. Companies like CI, HCA, AVTR and THC can outperform.

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Bausch + Lomb (BLCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised

by Zacks Equity Research

Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.

BLCO vs. AVTR: Which Stock Is the Better Value Option?

by Zacks Equity Research

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?

by Zacks Equity Research

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio

by Zacks Equity Research

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

BLCO or AVTR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Pediatrix Medical Group, Inc. (MD) Up 11% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Pediatrix Medical Group, Inc. (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BLCO or AVTR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

BLCO vs. AVTR: Which Stock Is the Better Value Option?

New Strong Sell Stocks for February 20th

by Zacks Equity Research

HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.

Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down

by Zacks Equity Research

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.

Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics

by Zacks Equity Research

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

ELV vs. AVTR: Which Stock Is the Better Value Option?

by Zacks Equity Research

ELV vs. AVTR: Which Stock Is the Better Value Option?

Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

by Zacks Equity Research

Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.